Status:
RECRUITING
Light Therapy Intervention in Individuals With Parkinson's Disease
Lead Sponsor:
University of Delaware
Collaborating Sponsors:
NeuroThera
Conditions:
Parkinson Disease
Eligibility:
All Genders
50-80 years
Phase:
NA
Brief Summary
The study looks to investigate the effects that light therapy delivered to the frontal cortex could have on Parkinson's disease related symptoms ( both cognitive and motor). The therapy is a non invas...
Eligibility Criteria
Inclusion
- Diagnosis of Parkinson disease
Exclusion
- Participants who are unable to comply with study visit/testing requirements (e.g.
- participants who cannot go off PD medication for the pre-, post-, and 3-month assessments).
- Participants who are unable to provide consent.
- Participants with a Deep Brain Stimulation (DBS) device.
- Participants who have a history of a psychiatric disorder
- Participants with PD who have other concurrent movement/neurological conditions, including dystonia, dementia, epilepsy etc.
- Participants with a clinical diagnosis of PD that is not considered primary (e.g.
- vascular parkinsonism) or participants where an atypical form of parkinsonism is suspected (e.g., progressive supranuclear palsy, multiple system atrophy).
- Participants with a history of cancer (whether treated with chemotherapy and/or radiotherapy or not).
- Participants with a history of a recent concussion or any facial, neck, or head injury within the last 6 months. UD IRB Approved: 03/12/2025 IRBNet ID#: 2277769-2 I/C from Rev. 01/2024 Page 3 of 10 Participant's Initial's \_\_\_\_\_\_\_\_
- Known injury or disease that might interfere with motor function in the proposed experiments (e.g., stroke, traumatic brain injury, extrapyramidal dysfunction, neuromuscular disease, orthopedic problems that impair movement).
- Participants with a history of photosensitivity.
- Participants who are not able to walk unassisted for 2 minutes
Key Trial Info
Start Date :
April 4 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 30 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06916260
Start Date
April 4 2025
End Date
July 30 2026
Last Update
April 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Delaware STAR Tower
Newark, Delaware, United States, 19711